Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 4
2(100.0%)
2Total
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03658889Completed

Assessment of Giant Cell Arteritis Medical Practices in France

Role: collaborator

NCT03746860Completed

N.I.S of AIT in Adult Patients With House Dust Mite Allergy in Real Practice in France

Role: collaborator

NCT03102450Phase 4Completed

Contraceptive Efficacy, Tolerance and Acceptability of a Benzalkonium Chloride Spermicide Cream In Women Aged Over 40 Years of Age

Role: collaborator

NCT02968979Completed

Non-interventional Study to Assess the Frequency of Cachexia in Patients With Non-small Cell Lung Cancer.

Role: collaborator

NCT01241526Phase 4Completed

The COPD Patient Management European Trial (COMET)

Role: collaborator

All 5 trials loaded